Breaking News Instant updates and real-time market news.

MYL

Mylan

$40.09

0.38 (0.96%)

13:42
06/12/17
06/12
13:42
06/12/17
13:42

Mylan: ISS recommendation to oust board 'simply irrational,' Bloomberg reports

Responding to ISS' recommendation for Mylan shareholders to oust the drugmaker's board, a Mylan spokeswoman told Bloomberg that its investors are aware that the board has "overseen a period of strong and sustainable long-term growth," and believes the recommendation to remove the board "and leave the company without any leadership is simply irrational and not in shareholders' best interests." The ISS report, which said Mylan's directors failed to stop "significant destruction in shareholder value" and faulted the board for making "egregious" decisions on pay, follows a similar report last week from Glass Lewis & Co, Bloomberg notes. Reference Link

  • 03

    Sep

  • 09

    Oct

MYL Mylan
$40.09

0.38 (0.96%)

05/22/17
LEHM
05/22/17
DOWNGRADE
Target $17
LEHM
Equal Weight
Momenta downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Douglas Tsao downgraded Momenta Pharmaceuticals (MNTA) to Equal Weight citing the likelihood of generic manufacturers, most notably Mylan (MYL), winning approval for generic Copaxone in the coming months. The approvals could come before Momenta and its partner Sandoz win approval themselves for the 40mg dose, Tsao tells investors in a research note. He lowered his price target for the shares to $17 from $20.
05/22/17
LEHM
05/22/17
UPGRADE
Target $50
LEHM
Overweight
Mylan upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Douglas Tsao upgraded Mylan (MYL) to Overweight saying the chances of the company winning approval for its generic version of Copaxone this year are better than current market expectations. The approval come as soon as next month, Tsao tells investors in a research note. The analyst coupled the upgrade with a downgrade of Copaxone maker Momenta Pharmaceuticals to Equal Weight. The selloff in Mylan following the Q1 disclosure of deficiencies to Advair create a buying opportunity, the analyst contends. He raised his price target for the shares to $50 from $47. Mylan closed Friday down 21c to $37.94.
05/31/17
WELS
05/31/17
NO CHANGE
WELS
Market Perform
Pension fund campaign a short-term negative for Mylan, says Wells Fargo
Wells Fargo analyst David Maris believes the campaign by four major pension funds to oppose the re-election of six directors is short-term negative for Mylan but has the potential to be a longer term positive. The campaign may pose a distraction to management, but if successful, it could address some governance concerns regarding compensation and performance at the company, Maris tells investors in a research note. The analyst has a Market Perform rating on Mylan shares.
06/12/17
SBSH
06/12/17
NO CHANGE
Target $38
SBSH
Buy
Citi says CRL for Coherus not worst case scenario
Citi analyst Mohit Bansal says Coherus Biosciences' (CHRS) complete response letter for its biosimilar version of Neulasta, while "clearly a negative outcome," is not the worst case scenario since the FDA did not ask for another study. The analyst sees a one year delay, which impacts his discounted free cash flow model by $5 per share. Coherus in premarket trading is down 30%, or $6.25, to $14.40. A one year delay would mean Coherus' CHS-1701 could still be on markets at the same time as competition from Mylan (MYL) and ahead of Sandoz's approval in 2019, Bansal tells investors in a research note. The analyst has a Buy rating on Coherus with a $38 price target.

TODAY'S FREE FLY STORIES

IJR

iShares Core S&P Small Cap ETF

$75.20

0.57 (0.76%)

06:38
11/21/17
11/21
06:38
11/21/17
06:38
Technical Analysis
iShares Core S&P Small Cap ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GHM

Graham

$19.21

0.35 (1.86%)

06:37
11/21/17
11/21
06:37
11/21/17
06:37
Hot Stocks
Graham announces two new orders totalling $6.4M »

Graham Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

EEM

MSCI Emerging Markets Index

$47.06

0.24 (0.51%)

06:37
11/21/17
11/21
06:37
11/21/17
06:37
Technical Analysis
MSCI Emerging Markets Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$72.05

0.72 (1.01%)

, BNPQY

BNP Paribas

$37.00

-0.225 (-0.60%)

06:37
11/21/17
11/21
06:37
11/21/17
06:37
Periodicals
FSB drops Citi, BNP in regulation rankings, Bloomberg reports »

The Financial Stability…

C

Citi

$72.05

0.72 (1.01%)

BNPQY

BNP Paribas

$37.00

-0.225 (-0.60%)

CS

Credit Suisse

$16.12

0.02 (0.12%)

JPM

JPMorgan

$99.01

0.87 (0.89%)

RY

Royal Bank of Canada

$78.93

-0.1 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 29

    Nov

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

EWW

iShares MSCI Mexico

$50.00

-0.26 (-0.52%)

06:37
11/21/17
11/21
06:37
11/21/17
06:37
Technical Analysis
iShares MSCI Mexico: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UUP

PowerShares DB US Dollar Index Up

$24.46

0.12 (0.49%)

06:36
11/21/17
11/21
06:36
11/21/17
06:36
Technical Analysis
PowerShares DB US Dollar Index Up: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UDN

PowerShares DB US Dollar Index Down

$22.02

-0.1052 (-0.48%)

06:35
11/21/17
11/21
06:35
11/21/17
06:35
Technical Analysis
PowerShares DB US Dollar Index Down: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALO

Alio

$3.31

-0.1 (-2.93%)

06:35
11/21/17
11/21
06:35
11/21/17
06:35
Downgrade
Alio rating change  »

Alio downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEXA

Nexa Resources

$16.01

0.17 (1.07%)

06:35
11/21/17
11/21
06:35
11/21/17
06:35
Initiation
Nexa Resources initiated  »

Nexa Resources initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FFIC

Flushing Financial

$27.75

0.31 (1.13%)

06:35
11/21/17
11/21
06:35
11/21/17
06:35
Conference/Events
Flushing Financial management to meet with Piper Jaffray »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

HRL

Hormel Foods

$33.40

0.28 (0.85%)

06:35
11/21/17
11/21
06:35
11/21/17
06:35
Earnings
Hormel Foods reports Q4 EPS 41c, consensus 40c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

SPN

Superior Energy

$8.81

-0.14 (-1.56%)

06:34
11/21/17
11/21
06:34
11/21/17
06:34
Upgrade
Superior Energy rating change  »

Superior Energy upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSCT

ForeScout

$26.94

1.39 (5.44%)

06:34
11/21/17
11/21
06:34
11/21/17
06:34
Initiation
ForeScout initiated  »

ForeScout initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

GSV

Gold Standard Ventures

$1.49

0.02 (1.36%)

06:33
11/21/17
11/21
06:33
11/21/17
06:33
Hot Stocks
Gold Standard Ventures announces results from drilling in Carlin Trend »

Gold Standard Ventures…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNC

SS&C

$39.69

-0.25 (-0.63%)

06:32
11/21/17
11/21
06:32
11/21/17
06:32
Upgrade
SS&C rating change  »

SS&C upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRAI

CRA International

$45.80

-0.42 (-0.91%)

06:31
11/21/17
11/21
06:31
11/21/17
06:31
Conference/Events
CRA International management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

BSET

Bassett Furniture

$38.55

-1.25 (-3.14%)

06:30
11/21/17
11/21
06:30
11/21/17
06:30
Conference/Events
Bassett Furniture management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

AKS

AK Steel

$4.63

0.12 (2.66%)

06:30
11/21/17
11/21
06:30
11/21/17
06:30
Upgrade
AK Steel rating change  »

Credit Suisse sees margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOFI

BofI Holding

$25.70

-0.15 (-0.58%)

06:26
11/21/17
11/21
06:26
11/21/17
06:26
Conference/Events
BofI Holding management to meet with Craig Hallum »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

  • 30

    Nov

NEXA

Nexa Resources

$16.01

0.17 (1.07%)

06:25
11/21/17
11/21
06:25
11/21/17
06:25
Initiation
Nexa Resources initiated  »

Nexa Resources initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AYR

Aircastle

$23.35

-0.06 (-0.26%)

06:24
11/21/17
11/21
06:24
11/21/17
06:24
Conference/Events
Aircastle management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

DHI

D.R. Horton

$48.20

0.07 (0.15%)

, MHK

Mohawk

$276.74

4.54 (1.67%)

06:24
11/21/17
11/21
06:24
11/21/17
06:24
Recommendations
D.R. Horton, Mohawk, Comcast analyst commentary  »

D.R. Horton added to US 1…

DHI

D.R. Horton

$48.20

0.07 (0.15%)

MHK

Mohawk

$276.74

4.54 (1.67%)

CMCSA

Comcast

$35.83

-0.33 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

ADTN

Adtran

$21.65

0.4 (1.88%)

06:23
11/21/17
11/21
06:23
11/21/17
06:23
Conference/Events
Adtran management to meet with Derxel Hamilton »

Meeting to be held in St.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

VRTV

Veritiv

$24.60

0.1 (0.41%)

06:23
11/21/17
11/21
06:23
11/21/17
06:23
Upgrade
Veritiv rating change  »

Veritiv upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVGO

Broadcom

$274.88

3.02 (1.11%)

, QCOM

Qualcomm

$66.47

-0.25 (-0.37%)

06:23
11/21/17
11/21
06:23
11/21/17
06:23
Periodicals
Broadcom mulls significant changes to Qualcomm's patent business, Reuters says »

As part of its $103B bid…

AVGO

Broadcom

$274.88

3.02 (1.11%)

QCOM

Qualcomm

$66.47

-0.25 (-0.37%)

AAPL

Apple

$169.98

-0.17 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 06

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.